Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients

NCT02256579 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2014-10-03

No results posted yet for this study

Summary

This study is to investigate clinical utility of beta2 microglobulin as an early marker for renal dysfunction caused by Tenofovir in Vietnamese HIV-infected patients.

Conditions

  • HIV Infection
  • Renal Function Disorder
  • Renal Tubular Disorder

Sponsors & Collaborators

  • National Center for Global Health and Medicine, Japan

    lead OTHER_GOV

Principal Investigators

  • Shinichi Oka, MD. PhD · National Center for Global Health and Medicine

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-11-30
Completion
2017-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02256579 on ClinicalTrials.gov